Investigations
Japan Links 81 Deaths to new Lung Cancer Drug Thu, 5 Dec 2002 Now a days, the fate of a drug depends not so much on its efficacy and safety, but rather on the financial needs of the manufacturer and the company’s ability to round up an “independent” panel of…
FDA Is Flexing Less Muscle where Safety is the Issue – Wash Post Thu, 18 Nov 2004 The Washington Post examines FDA’s record of surveillance and the evidence is clear: since 1992 when Congress required drug companies to pay users fees to the FDA, the agency’s focus changed from safety…
NIH Under Fire: Longtime Favorite of Congress – Wash Post / WSJ Sun, 27 Jun 2004 Under fire from Congress with evidence of NIH staff engaging in secret outside contracts and consultancies, NIH Director, Dr. Elias Zerhouni, turned a corner. He acknowledged the problem at a hearing (June 22) of…
According to a investigative report issued by the Israeli Health Ministry, the doctors "conducted illegal and unethical testing on thousands of elderly patients for years.
The New York Times reports that a Maryland psychiatrist, Dr. Peter Gleason, was handcuffed and arrested in March and charged with criminal promotion of a drug "for purposes other than those approved by the federal government."
The New York Times reports that former FDA Commissioner, Dr. Lester Crawford "is under criminalo investigation by a federal grand jury over accusations of financial improprieties and false statements to Congress."
"The subpoena shows that the government is investigating Guidant for possible violations of health care statutes
2005 was a year in which some of Big Pharma’s clandestine relationships with an army of bought-and- paid- for minions in academia,
government, congress, the media, and front organizations were uncovered–in courtrooms, investigative books, reports and films.
In its continuing coverage of corrupt clinical drug trial practices, Bloomberg News reports that all three founders of SFBC International, one of the largest clinical trial business operations that had failed to even screen human subjects for turberculosis, and threatened others with deportation if they refused to become guinea pigs, quit after the Senate Finance committee began investigating drug trial safety issues:
Bloomberg News published an update to its sensational special report: Big Pharma’s Shameful Secret
see: https://ahrp.org/infomail/05/11/03.php
Fri, 20 May 2005 ARMA was a government-sponsored, $41 million experiment involving 861 critically ill patients with severe lung injury–i.e., acute respiratory distress syndrome (ARDS). It has been at the center of continuing debate prompted by revelations that researchers at 14 of the nation’s major medical research institutions comprising the…
